Logo image of HCM-H.CA

HIGHCLIFF METALS CORP (HCM-H.CA) Stock Fundamental Analysis

TSX-V:HCM-H - TSX Venture Exchange - CA42984P1062 - Common Stock - Currency: CAD

0.1  -0.01 (-9.09%)

Fundamental Rating

2

HCM-H gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 822 industry peers in the Metals & Mining industry. While HCM-H seems to be doing ok healthwise, there are quite some concerns on its profitability. HCM-H has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

HCM-H had negative earnings in the past year.
In the past year HCM-H had a positive cash flow from operations.
In the past 5 years HCM-H reported 4 times negative net income.
In the past 5 years HCM-H always reported negative operating cash flow.
HCM-H.CA Yearly Net Income VS EBIT VS OCF VS FCFHCM-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

HCM-H's Return On Assets of -3.88% is fine compared to the rest of the industry. HCM-H outperforms 76.36% of its industry peers.
Industry RankSector Rank
ROA -3.88%
ROE N/A
ROIC N/A
ROA(3y)867.2%
ROA(5y)413.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HCM-H.CA Yearly ROA, ROE, ROICHCM-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 10K -10K 20K -20K

1.3 Margins

HCM-H does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HCM-H.CA Yearly Profit, Operating, Gross MarginsHCM-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

4

2. Health

2.1 Basic Checks

HCM-H has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for HCM-H. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HCM-H.CA Yearly Shares OutstandingHCM-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M
HCM-H.CA Yearly Total Debt VS Total AssetsHCM-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -18.47, we must say that HCM-H is in the distress zone and has some risk of bankruptcy.
HCM-H has a worse Altman-Z score (-18.47) than 74.06% of its industry peers.
HCM-H has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Altman-Z -18.47
ROIC/WACCN/A
WACCN/A
HCM-H.CA Yearly LT Debt VS Equity VS FCFHCM-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 -10M -20M -30M -40M

2.3 Liquidity

A Current Ratio of 0.94 indicates that HCM-H may have some problems paying its short term obligations.
HCM-H has a Current ratio (0.94) which is comparable to the rest of the industry.
HCM-H has a Quick Ratio of 0.94. This is a bad value and indicates that HCM-H is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.94, HCM-H perfoms like the industry average, outperforming 44.48% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.94
HCM-H.CA Yearly Current Assets VS Current LiabilitesHCM-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

0

3. Growth

3.1 Past

The earnings per share for HCM-H have decreased strongly by -100.20% in the last year.
EPS 1Y (TTM)-100.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HCM-H.CA Yearly Revenue VS EstimatesHCM-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2020 2021 2022 2023 2024
HCM-H.CA Yearly EPS VS EstimatesHCM-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2020 2021 2022 2023 2024 -0.1 -0.2 -0.3 -0.4 -0.5

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCM-H. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HCM-H.CA Price Earnings VS Forward Price EarningsHCM-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, HCM-H is valued cheaply inside the industry as 89.45% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 982.63
EV/EBITDA N/A
HCM-H.CA Per share dataHCM-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0 -0 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HCM-H!.
Industry RankSector Rank
Dividend Yield N/A

HIGHCLIFF METALS CORP

TSX-V:HCM-H (3/7/2025, 7:00:00 PM)

0.1

-0.01 (-9.09%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners6.01%
Ins Owner ChangeN/A
Market Cap1.87M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF 982.63
P/OCF 982.63
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.1%
OCF(TTM)0
OCFY0.1%
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.88%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)867.2%
ROA(5y)413.55%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.94
Altman-Z -18.47
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y84.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y96.11%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y96.06%
OCF growth 3YN/A
OCF growth 5YN/A